CancerBIOGEN.com

BERLIN, Thursday 24 September New data presented this week at the joint ECCO-ESMO multidisciplinary congress in Berlin, show that AstraZeneca s oral anti- cancer . … AstraZeneca is one of the world’s leading pharmaceutical companies with healthcare sales of US$ 31.6 billion and is a leader in gastrointestinal , cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. For more information about AstraZeneca, please visit: …

View post:
Two Phase Iii Studies Confirm Efficacy Of Iressa In EGFR MUTATION+ …

Digg

Stumble Upon

Del.icio.us

Buzz

OPAXIO(TM) Phase II Trial in Esophageal Cancer to be Presented in Proffered Session at the International Society of Gastrointestinal Oncology Annual Meeting. Pharma Industry News Login or register to post comments …

More:
OPAXIO(TM) Phase II Trial in Esophageal Cancer to be Presented in …

Digg

Stumble Upon

Del.icio.us

Buzz

Issels said his findings, presented at the ECCO-ESMO European cancer congress in Berlin, showed that soft tissue sarcoma patients receiving the targeted heat therapy plus chemotherapy fared better on all outcome measurements. …

Read more from the original source:
Heat to be used for cancer treatment : Ghana Business News

Digg

Stumble Upon

Del.icio.us

Buzz

Researchers told Europe’s biggest cancer congress, ECCO 15 ESMO 34 in Berlin, that the findings of their study indicate that doctors need to start considering heart-related side effects when they prescribe endocrine therapy for …

Go here to read the rest:
Hormone Therapy Linked To Increased Risk Of Heart Disease In Male …

Digg

Stumble Upon

Del.icio.us

Buzz

Issels said his findings, presented at the ECCO-ESMO European cancer congress in Berlin, showed that soft tissue sarcoma patients receiving the targeted heat therapy plus chemotherapy “fared better on all outcome measurements.” …

The rest is here:
NewsDaily: Heat helps in cancer treatment

Digg

Stumble Upon

Del.icio.us

Buzz

Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal ( GI ) cancers will be presented at Europe’s largest cancer congress, ECCO 15 - ESMO 34, in Berlin today (Monday …

See the original post:
New blood tests promise simple, cost-effective diagnosis of …

Digg

Stumble Upon

Del.icio.us

Buzz

Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal ( GI ) cancers will be presented at Europe’s largest cancer congress, ECCO 15 ESMO 34 [1], in Berlin today (Monday …

The rest is here:
New blood tests for gastrointestinal cancers from medicineworld.org

Digg

Stumble Upon

Del.icio.us

Buzz

Berlin, Germany: Promising results from two new blood tests that can aid in the early identification of patients with gastrointestinal ( GI ) cancers will be presented at Europe’s largest cancer congress, ECCO 15 ESMO 34 [1], …

Read the rest here:
New blood tests may mean simple diagnosis of gastrointestinal …

Digg

Stumble Upon

Del.icio.us

Buzz

In analysis presented by Eric Van Cutsem, MD, at the ESMO Gastrointestinal Cancer Congress in June in Barcelona, there was no additional gastrointestinal perforation, postoperative bleeding, wound-healing complications, or hypertension …

Read more:
C3: Colorectal Cancer Coalition Archive Colorectal Cancer News …

Digg

Stumble Upon

Del.icio.us

Buzz

The men who exercised more intensely were much less likely to die from lung cancer , and cancers of the gastrointestinal tract. Now the numbers with a little explanation. Men who had an increase of 1.2 METs in metabolic activity were …

The rest is here:
Intense Daily Exercise Slashes Lung Cancer Mortality in Men

Digg

Stumble Upon

Del.icio.us

Buzz